!1 New UpdateClick here for latest updates
COVID-19 vaccination for 18-44 age group begins in J-Ks Poonch
Poonch district of Jammu and Kashmir has started COVID-19 vaccination for the beneficiaries between 18-44 years on Wednesday.
38,52,38,220 samples have been tested up to June 16 in the country including 19,31,249 samples tested yesterday: ICMR
India reports 67,208 new COVID19 cases and 2,330 deaths
- Total cases: 2,97,00,313
- Total discharges: 2,84,91,670
- Death toll: 3,81,903
- Active cases: 8,26,740 (lowest after 71 days)
- Total Vaccination: 26,55,19,251
Bharat Biotech and World Health Organisation’s (WHO) pre-submission meeting on June 23rd, says a WHO document
Kerala unlocks in graded manner from today
#COVID19 | Kerala unlocks in graded manner from today after decline in daily-reported cases, however, complete lock… https://t.co/838jg8YjEb
— ANI (@ANI) 1623898228000
S. Africa records over 13,000 COVID-19 cases in a day
Cases of the coronavirus in South Africa continued surging as 13,246 new cases were registered over the past 24 hours, the highest number since January this year, said the National Institute for Communicable Diseases (NICD) on Wednesday night.
Vaccine effort turns into slog as infectious variant spreads
- As cases tumble and states reopen, the potential final stage in the US campaign to vanquish COVID-19 is turning into a slog, with a worrisome variant gaining a bigger foothold and lotteries and other prizes failing to persuade some Americans to get vaccinated.
- “The last half, the last mile, the last quarter-mile always requires more effort,” Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, said Wednesday.
China reports 19 new COVID-19 cases on June 16 vs 21 a day earlier
The total number of confirmed COVID-19 cases in mainland China stood at 91,511 by the end of June 16, with the death toll unchanged at 4,636.
Fully vaccinated people in UK could be allowed to travel to amber list countries
Reports –The Telegraph
Interim trial data shows low effectiveness for CureVac shot
- German vaccine maker CureVac has said that interim data from late-stage testing of its coronavirus shot show a comparatively low effectiveness in protecting people against COVID-19.
- The results on Wednesday appear to be a significant setback for CureVac’s efforts to develop a coronavirus vaccine, and the company’s stock value tumbled in after-hours trading.
- While not all the data from its trial involving 40,000 participants in Latin America and Europe have been assessed yet, the company said interim results show the vaccine has an efficacy of 47% against COVID-19 disease of any severity.
At least 19 COVID-19 strains identified in Brazil
- At least 19 variants of coronavirus have been identified in the Brazilian state of Sao Paulo, Instituto Butantan, a Brazilian biologic research center, said in a statement.
- “There are 19 coronavirus variants circulating in the state of Sao Paulo, with the P.1 (Amazonian) strain prevailing in 89.9 per cent of cases,” the statement said. This is followed by strain B.1.1.7 (UK), which accounts for 4.2 per cent.
Portugal’s surge in cases highest since February
The European Union country reported 1,350 new cases on Wednesday, the highest daily total since February. Experts say the delta variant first identified in India may be driving the spread. The Lisbon region has accounted for almost 1,000 of the new cases.
